Panel Discussion | Complementary supplements: Designing the next chapter of weight management beyond GLP-1s

As GLP-1 medications transform the weight management category, new opportunities are emerging for the nutraceutical industry to support nutrient deficiency, muscle mass and metabolic health. With the medications becoming more widely available and in simpler formats, its long-term market impact includes a halo-effect on non-users. This panel will explore how GLP‑1 treatments are reshaping consumer needs and highlight evidence‑backed supplement strategies that promote appetite control. We will also examine the challenge of rebound weight gain and discuss innovative approaches to nutrition and product design that can support consumers throughout their weight management journey.

Underwriting Partner: Biotexia (previously Fytexia)

By viewing this session, the sponsor may contact you with product and service information. You can unsubscribe or contact the sender anytime. See the Privacy Policy (https://privacy.informa.com/policies/en/) for details.

This session will be recorded on site and will be made available for on-demand viewing from 11th May till 26th June 2026.